PMC:7546122 / 5513-5753 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T26","span":{"begin":56,"end":62},"obj":"Body_part"},{"id":"T27","span":{"begin":116,"end":120},"obj":"Body_part"}],"attributes":[{"id":"A26","pred":"fma_id","subj":"T26","obj":"http://purl.org/sig/ont/fma/fma62970"},{"id":"A27","pred":"fma_id","subj":"T27","obj":"http://purl.org/sig/ont/fma/fma68646"}],"text":"SARS-CoV-2 nAb titers were determined in IVIG and human plasma samples that were used undiluted, or prediluted with cell culture medium 1:4, 1:5, 1:10, or 1:20 depending on sample amount available, and then serially diluted in 2-fold steps."}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T27","span":{"begin":0,"end":8},"obj":"Disease"}],"attributes":[{"id":"A27","pred":"mondo_id","subj":"T27","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"}],"text":"SARS-CoV-2 nAb titers were determined in IVIG and human plasma samples that were used undiluted, or prediluted with cell culture medium 1:4, 1:5, 1:10, or 1:20 depending on sample amount available, and then serially diluted in 2-fold steps."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T48","span":{"begin":50,"end":55},"obj":"http://purl.obolibrary.org/obo/NCBITaxon_9606"},{"id":"T49","span":{"begin":56,"end":62},"obj":"http://purl.obolibrary.org/obo/UBERON_0001969"},{"id":"T50","span":{"begin":116,"end":120},"obj":"http://purl.obolibrary.org/obo/GO_0005623"},{"id":"T51","span":{"begin":138,"end":142},"obj":"http://purl.obolibrary.org/obo/CLO_0053794"}],"text":"SARS-CoV-2 nAb titers were determined in IVIG and human plasma samples that were used undiluted, or prediluted with cell culture medium 1:4, 1:5, 1:10, or 1:20 depending on sample amount available, and then serially diluted in 2-fold steps."}

{"project":"LitCovid-sentences","denotations":[{"id":"T34","span":{"begin":0,"end":240},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"SARS-CoV-2 nAb titers were determined in IVIG and human plasma samples that were used undiluted, or prediluted with cell culture medium 1:4, 1:5, 1:10, or 1:20 depending on sample amount available, and then serially diluted in 2-fold steps."}

{"project":"LitCovid-PubTator","denotations":[{"id":"115","span":{"begin":0,"end":10},"obj":"Species"},{"id":"116","span":{"begin":50,"end":55},"obj":"Species"}],"attributes":[{"id":"A115","pred":"tao:has_database_id","subj":"115","obj":"Tax:2697049"},{"id":"A116","pred":"tao:has_database_id","subj":"116","obj":"Tax:9606"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"SARS-CoV-2 nAb titers were determined in IVIG and human plasma samples that were used undiluted, or prediluted with cell culture medium 1:4, 1:5, 1:10, or 1:20 depending on sample amount available, and then serially diluted in 2-fold steps."}